RNA delivery

Boston, Massachusetts | April 13, 2026 Vivatides Therapeutics has announced the successful completion of a $54 million oversubscribed Series...

VANCOUVER, Canada — December 4, 2025 — Renaissance BioScience Corp. announced that the Mexican patent office has granted a...